Director/PDMR shareholding

July 28, 2018

The Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on 25 July 2018, it purchased 171,000 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") at 2.85p per Ordinary Share (the “Purchase”). Following the purchase, Vulpes has a total direct and indirect interest in 55,388,431 equivalent to 18.76% of Proteome Sciences' total issued share capital.


Back to News